Has Timoteo Torres Santiago, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,502 in general payments to Timoteo Torres Santiago, MD across 35 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Timoteo Torres Santiago, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Timoteo Torres Santiago, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Timoteo Torres Santiago, MD

Urology · Caguas, PRNPI 1265467161

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Boston Scientific at 31.1% of the total. Reporting peaked in 2022 at $976 and has fallen 53.3% since, to $456 in 2025.

$3,502in general payments, 2019–2025

Across 35 payments — averaging $100.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$1K
Verity Pharmaceuticals Inc.$370
Teleflex LLC$268
Merck$244
Johnson & Johnson$238
E.r. Squibb & Sons, L.L.C.$153
plus $1K from 11 others

What the payments were for

Food & beverage$3,502100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	11	$1,091
Verity Pharmaceuticals Inc.	3	$370
Teleflex LLC	2	$268
Merck	2	$244
Johnson & Johnson	2	$238
E.r. Squibb & Sons, L.L.C.	2	$153
Ferring Pharmaceuticals Inc.	2	$146
Neotract Inc.	2	$134
Travere Therapeutics, Inc.	1	$130
BD	1	$130
Progenics Pharmaceuticals, Inc.	1	$124
Urogen Pharma, Inc.	1	$114
Pfizer	1	$100
Olympus Latin America, Inc.	1	$100
AbbVie	1	$85
Tolmar Pharmaceuticals, Inc.	1	$64
PBG Puerto Rico LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

UroLift$268
GENERAL BPH$256
TRELSTAR$245
KEYTRUDA$244
Erleada$238
(815) Thiola$130
Proxis Ureteral Access Sheath$130
GENERAL KIDNEY STONE DISEASE$130
ADSTILADRIN$128
OPDIVO$125
TLANDO$125
RYBREVANT$125
AKEEGA$125
GENERAL - THERAPIES$125
PYLARIFY$124
JELMYTO$114
DARZALEX$113
TALVEY$113
REZUM$104
XTANDI$100

How this compares

$3,502 in reported general payments places this provider in the 60th percentile of 122 urology providers in Puerto Rico.

See all urology providers in Puerto Rico →

Medicare billing

Part B allowed, 2024

$2,083

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	123	$1,705
Finasteride	54	$758
Sildenafil Citrate	29	$549
Terazosin Hcl	16	$355
Bicalutamide	13	$330
Cephalexin	28	$173
Ciprofloxacin Hcl	12	$87

Paid to pharmacies, not to this prescriber.

Other urology in Caguas

Antonio Yulian ValentinCaguas$48K
Alvin Lopez-PujalsCaguas$27K
Ramon Ramos CartagenaCaguas$5K
Claudio Bernaschina BobadillaPonce$132K
Mariela Martinez-RiveraPonce$105K
Freddy Mendez TorresCayey$95K
Luis AmbertRio Piedras$64K
Jorge Crespo CarrilloRio Piedras$62K
Ronald Cadillo ChavezBayamon$61K
Andres Perez RomanSan Juan$58K

See the full list for Puerto Rico →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →